Because murine models of APL were designed to target PML-RARA expression to myeloid-restricted cells, we and others have suggested that myeloid-restricted disease might result from targeted expression of PML-RARA to the promyelocyte compartment [6], [7], [8], [9], [10]. This evidence concerns the gene RARA and acute promyelocytic leukemia.